| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.ASN.0000014252.37680.E4 |
| P698 | PubMed publication ID | 12039975 |
| P2093 | author name string | Hong-Jian Zhu | |
| Richard J Johnson | |||
| Hui Y Lan | |||
| Jin H Li | |||
| Xiao R Huang | |||
| Kar N Lai | |||
| P433 | issue | 6 | |
| P304 | page(s) | 1464-1472 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation | |
| P478 | volume | 13 |
| Q53605893 | A critical look at growth factors and epithelial-to-mesenchymal transition in the adult kidney. Interrelationships between growth factors that regulate EMT in the adult kidney. |
| Q40512793 | A novel pathological role of p53 in kidney development revealed by gene-environment interactions |
| Q40467044 | Adrenomedullin impairs the profibrotic effects of transforming growth factor-beta1 through recruiting Smad6 protein in human renal tubular cells. |
| Q30445160 | Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway |
| Q33711306 | Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling |
| Q36846132 | Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats |
| Q36310340 | Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases |
| Q34170852 | Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro |
| Q38989903 | Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro |
| Q35995082 | Beneficial effects of intramyocardial mesenchymal stem cells and VEGF165 plasmid injection in rats with furazolidone induced dilated cardiomyopathy |
| Q54439738 | C-reactive protein promotes acute renal inflammation and fibrosis in unilateral ureteral obstructive nephropathy in mice. |
| Q38687425 | Diabetic cardiomyopathy: role of the E3 ubiquitin ligase |
| Q38494989 | Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy |
| Q46753406 | Disturbance of lymph circulation develops renal fibrosis in rats with or without contralateral nephrectomy |
| Q91650519 | Diverse Role of TGF-β in Kidney Disease |
| Q92591876 | Effect of Jiawei Fengshining on Synovial Cell Apoptosis and TGF-β1/Smad Signaling Pathway in Rats with Rheumatoid Arthritis |
| Q39522684 | Effect of TGF-β1 Stimulation on the Smad Signal Transduction Pathway of Human Peritoneal Mesothelial Cells |
| Q64272127 | Effect of canonical NF-κB signaling pathway on the differentiation of rat dental epithelial stem cells |
| Q43693945 | Effect of mycophenolic acid on cyclosporin A-induced fibronectin expression in rat mesangial cells |
| Q43102100 | Effects of Arkadia on airway remodeling through enhancing TGF-beta signaling in allergic rats |
| Q54394597 | Effects of silencing transforming growth factor-β1 by RNA interference plasmid on rat renal allograft fibrosis using Smads pathway. |
| Q47881354 | Epithelial-to-mesenchymal transition in fibrosis: collagen type I expression is highly upregulated after EMT, but does not contribute to collagen deposition |
| Q35039381 | Erythrophagocytosis of lead-exposed erythrocytes by renal tubular cells: possible role in lead-induced nephrotoxicity |
| Q39732359 | Erythropoietin suppresses epithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PK1) cell lines |
| Q39017725 | Evodiamine might inhibit TGF-beta1-induced epithelial-mesenchymal transition in NRK52E cells via Smad and PPAR-gamma pathway |
| Q41128554 | Expression of intronic miRNAs and their host gene Igf2 in a murine unilateral ureteral obstruction model |
| Q42656722 | Expression of transforming growth factor-beta (TGFbeta) and the TGFbeta signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation |
| Q54571621 | Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation. |
| Q35903089 | GQ5 Hinders Renal Fibrosis in Obstructive Nephropathy by Selectively Inhibiting TGF-β-Induced Smad3 Phosphorylation |
| Q41595360 | Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-beta2 signaling. |
| Q35111058 | Gpr48 deficiency induces polycystic kidney lesions and renal fibrosis in mice by activating Wnt signal pathway |
| Q37115414 | HDAC inhibitors in kidney development and disease |
| Q35791678 | Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction |
| Q36579290 | Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro |
| Q28569252 | Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury |
| Q35005695 | Honokiol ameliorates renal fibrosis by inhibiting extracellular matrix and pro-inflammatory factors in vivo and in vitro. |
| Q98195622 | Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis |
| Q35326035 | Identification of a microRNA signature in renal fibrosis: role of miR-21. |
| Q45899842 | Immunohistochemical evaluation of phosphorylated SMAD2/SMAD3 and the co-activator P300 in human glomerulonephritis: correlation with renal injury. |
| Q44081103 | Impact of repeated intravenous bone marrow mesenchymal stem cells infusion on myocardial collagen network remodeling in a rat model of doxorubicin-induced dilated cardiomyopathy |
| Q35587144 | Increased Expression of TGF-β Signaling Components in a Mouse Model of Fibrosis Induced by Submandibular Gland Duct Ligation |
| Q37668231 | Inflammation and EMT: an alliance towards organ fibrosis and cancer progression |
| Q38342047 | Infrequent alteration of the DPC4 tumor suppressor gene in renal cell carcinoma. |
| Q38783903 | Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin |
| Q48140192 | Irisin inhibits high glucose-induced endothelial-to-mesenchymal transition and exerts a dose-dependent bidirectional effect on diabetic cardiomyopathy |
| Q38756929 | Is there any role of epithelial to mesenchymal transition in the pathogenesis of contrast nephropathy? |
| Q51334626 | Isogenic mesenchymal stem cells transplantation improves a rat model of chronic aristolochic acid nephropathy via upregulation of hepatic growth factor and downregulation of transforming growth factor β1. |
| Q64913929 | Juglone in Oxidative Stress and Cell Signaling. |
| Q38624783 | Latent TGF-beta1 protects against crescentic glomerulonephritis |
| Q59132126 | Loss of Smad7 Promotes Inflammation in Rheumatoid Arthritis |
| Q43701818 | Low-dose paclitaxel ameliorates renal fibrosis in rat UUO model by inhibition of TGF-beta/Smad activity |
| Q38599408 | Mesenchymal stem cells as novel micro-ribonucleic acid delivery vehicles in kidney disease |
| Q36807057 | Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease |
| Q34468508 | MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis |
| Q38325122 | Modulation of the TGFbeta/Smad signaling pathway in mesangial cells by CTGF/CCN2. |
| Q36010095 | New insights into epithelial-mesenchymal transition in kidney fibrosis |
| Q37598306 | New insights into molecular mechanisms of diabetic kidney disease |
| Q42133227 | Oxytocin alleviates cisplatin-induced renal damage in rats |
| Q36330422 | P311 promotes renal fibrosis via TGFβ1/Smad signaling. |
| Q38967717 | Paricalcitol protects against TGF-β1-induced fibrotic responses in hypoxia and stabilises HIF-α in renal epithelia. |
| Q50057357 | Pathogenesis of non-alcoholic fatty liver disease mediated by YAP. |
| Q92844811 | Petchiether A attenuates obstructive nephropathy by suppressing TGF-β/Smad3 and NF-κB signalling |
| Q35553317 | Plasticity of kidney cells: Role in kidney remodeling and scarring |
| Q46702673 | Prevention of chronic allograft nephropathy with vitamin D. |
| Q57821113 | Proteasome biology and therapeutics in cardiac diseases |
| Q24318927 | RGC-32 mediates transforming growth factor-beta-induced epithelial-mesenchymal transition in human renal proximal tubular cells |
| Q50665394 | Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis. |
| Q28588339 | Response gene to complement 32 is essential for fibroblast activation in renal fibrosis |
| Q39814662 | Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis |
| Q35170428 | Role of tissue stroma in cancer cell invasion |
| Q50486496 | Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro. |
| Q21284189 | Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-beta1 signal transduction pathway in vivo and in vitro |
| Q37089449 | Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition |
| Q36673667 | Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs |
| Q26865998 | Smads as therapeutic targets for chronic kidney disease |
| Q37884486 | TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis |
| Q39418101 | TGFβ modulates cell-to-cell communication in early epithelial-to-mesenchymal transition |
| Q36321993 | Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo |
| Q36991087 | Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction |
| Q41859044 | The Pin 1 inhibitor juglone attenuates kidney fibrogenesis via Pin 1-independent mechanisms in the unilateral ureteral occlusion model |
| Q38301827 | The differential regulation of Smad7 in kidney tubule cells by connective tissue growth factor and transforming growth factor-beta1. |
| Q28506288 | The hippo pathway effector Yap controls patterning and differentiation of airway epithelial progenitors |
| Q39123810 | The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway |
| Q37760963 | The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology. |
| Q40467037 | The nephrotoxin ochratoxin A induces key parameters of chronic interstitial nephropathy in renal proximal tubular cells. |
| Q36857879 | The role of tubular epithelial-mesenchymal transition in progressive kidney disease. |
| Q36023612 | Therapeutic administration of Budesonide ameliorates allergen-induced airway remodelling |
| Q35076442 | Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy |
| Q54363671 | Tranilast prevents the progression of chronic cyclosporine nephrotoxicity through regulation of transforming growth factor β/Smad pathways. |
| Q33637779 | Transcriptome analysis of muskrat scented glands degeneration mechanism |
| Q35792147 | Transforming Growth Factor-β-Dependent and -Independent Pathways of Induction of Tubulointerstitial Fibrosis in β6−/− Mice |
| Q37972665 | Transforming growth factor-β/Smad signalling in diabetic nephropathy. |
| Q30484142 | Treatment of established peritoneal fibrosis by gene transfer of Smad7 in a rat model of peritoneal dialysis. |
| Q41575347 | Trps1 haploinsufficiency promotes renal fibrosis by increasing Arkadia expression |
| Q53455147 | Ubiquitination and regulation of Smad7 in the TGF-β1/Smad signaling of aristolochic acid nephropathy. |
| Q30499402 | Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney. |
| Q47998918 | Yap/Taz Deletion in Gli+ Cell-Derived Myofibroblasts Attenuates Fibrosis |
| Q91971092 | miR-130a-3p inhibition protects against renal fibrosis in vitro via the TGF-β1/Smad pathway by targeting SnoN |
| Q34124178 | miR-192 mediates TGF-beta/Smad3-driven renal fibrosis |
Search more.